LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $423,000 | -12.8% | 4,250 | 0.0% | 0.01% | -13.3% |
| Q2 2019 | $485,000 | +0.4% | 4,250 | +10.6% | 0.02% | -6.2% |
| Q1 2019 | $483,000 | -7.3% | 3,842 | 0.0% | 0.02% | -20.0% |
| Q4 2018 | $521,000 | -50.6% | 3,842 | 0.0% | 0.02% | -39.4% |
| Q3 2018 | $1,055,000 | +36.1% | 3,842 | +2.7% | 0.03% | +32.0% |
| Q2 2018 | $775,000 | +25.4% | 3,740 | 0.0% | 0.02% | +19.0% |
| Q1 2018 | $618,000 | +20.7% | 3,740 | 0.0% | 0.02% | +23.5% |
| Q4 2017 | $512,000 | +28.6% | 3,740 | +27.9% | 0.02% | +21.4% |
| Q3 2017 | $398,000 | +39.6% | 2,924 | +24.6% | 0.01% | +40.0% |
| Q2 2017 | $285,000 | +114.3% | 2,346 | +86.5% | 0.01% | +100.0% |
| Q1 2017 | $133,000 | +27.9% | 1,258 | +23.3% | 0.01% | 0.0% |
| Q4 2016 | $104,000 | – | 1,020 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |